By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Medco Health Solutions announced on Wednesday that it, its wholly owned subsidiary United BioSource, and Sanofi have entered into a global, multi-year agreement to improve patient care in real-world settings.

The partnership will leverage several capabilities, including personalized medicine and pharmacogenomics, health economics, and safety research, as well as clinical/adherence support.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.